The application relates to new piperazine- or morpholine-substituted azetidine derivatives of formula I. These compounds are antagonists at the neurokinin receptor and can be used for the treatment of gastrointestinal diseases. The application also relates to processes for the preparation of the compounds and to intermediates in said preparation.
该申请涉及式I的新型
哌嗪或
吗啡啶取代的
氮杂环丙烷衍
生物。这些化合物是神经激肽受体拮抗剂,可用于治疗胃肠疾病。该申请还涉及制备这些化合物的方法以及制备过程中的中间体。